Company intelligence / Profile preview

Nicosof

Ahmedabad, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Nicosof Pharmaceuticals is an Indian pharmaceutical company primarily focused on the marketing and distribution of generic antiviral medications. The company is best known for its brand Nicosof, which is a generic version of the direct-acting antiviral drug sofosbuvir used in the treatment of chronic hepatitis C infections. Nicosof Pharmaceuticals operates within the highly competitive Indian generic market, providing affordable access to critical therapies for liver diseases. The company's business model centers on the commercialization of high-demand generic formulations rather than novel drug discovery.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nicosof.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicosof.

Explore the full profile